Technology News and Research

RSS

Beaumont Health joins UHC and Novation to increase cost savings, improve supply chain performance

UHC announced today that Beaumont Health has partnered with UHC and its supply contracting company, Novation, on a new two-year initiative designed to increase cost savings and supply chain performance improvement.

25 Mar 2015

Confluence pharmaceuticals signs co-development and marketing agreement with AOP orphan for fragile X syndrome drug

Confluence is a biopharmaceutical company focused on developing therapeutic treatments for Fragile X Syndrome and Autism Spectrum Disorders. AOP is an Austrian based company specializing in the development and marketing of medicines for rare and complex diseases.

24 Mar 2015

GenVec reports record financial results for Q4 and fiscal year 2014

GenVec, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the year ended December 31, 2014, the company reported a net loss of $2.5 million, or $0.16 per share, compared with a net loss of $10.0 million, or $0.77 per share, for the year ended December 31, 2013.

24 Mar 2015

People who take many doses are more likely to crush tablets, reduce their effectiveness

People who take more than four doses of medicine a day appear more likely to crush tablets or open capsules potentially reducing their effectiveness, QUT research has found.

24 Mar 2015

Rigontec raises €4.8 million in second closing of Series A financing round

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, today announces it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor.

24 Mar 2015

Newly identified proteins could shed light on the mechanisms of ALS

Where ALS comes from and how it progresses are mysteries that continue to vex medical science. But recent research at Sweden's KTH Royal Institute of Technology has found three proteins that could shed some light on the mechanisms behind this deadly disease.

24 Mar 2015

Harmful effects of smoking may be reflected in the facial movements of unborn babies

The harmful effects of smoking during pregnancy may be reflected in the facial movements of mothers' unborn babies, new research has suggested.

24 Mar 2015

Snake-like robots follow the lead of real sidewinder rattlesnakes

Researchers at Carnegie Mellon University who develop snake-like robots have picked up a few tricks from real sidewinder rattlesnakes on how to make rapid and even sharp turns with their undulating, modular device.

24 Mar 2015

Harris Health System uses sign language video technology to communicate with hearing-impaired patients

Harris Health System is now using sign language video technology to better communicate with its hearing-impaired and hard-of-hearing patients.

24 Mar 2015

New targeted therapy promises to reduce frequency and intensity of breakouts

Acne, a scourge of adolescence, may be about to meet its ultra high-tech match. By using a combination of ultrasound, gold-covered particles and lasers, researchers from UC Santa Barbara and the private medical device company Sebacia have developed a targeted therapy that could potentially lessen the frequency and intensity of breakouts, relieving acne sufferers the discomfort and stress of dealing with severe and recurring pimples.

23 Mar 2015

TGAC plans to use miniaturised sequencing device to conduct live environmental surveillance

As one of the first research Institutes to take part in the MinION Access Programme (MAP) for portable DNA sequencing, introduced by Oxford Nanopore Technologies, The Genome Analysis Centre (TGAC)'s task force share their experience of the ground breaking trial so far.

From Oxford Nanopore Technologies 23 Mar 2015

Mast plans to develop vepoloxamer for chronic heart failure treatment

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, arterial disease and heart failure, today announced its plans to develop vepoloxamer (MST-188) for the treatment of patients with chronic heart failure.

23 Mar 2015

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

Cipher Pharmaceuticals Inc. today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma for moderate to severe plaque psoriasis and rheumatoid arthritis.

23 Mar 2015

EHT expert paper raises important and unanswered questions about safety of wearable tech

Wearable technology is raising health concerns worldwide. A recent New York Times article by Nick Bilton is raising important and unanswered questions about the safety of wearable tech, according to the non-profit research group, Environmental Health Trust.

23 Mar 2015

OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities.

23 Mar 2015

Study: Medical practices need support and guidance to adopt new payment models

Physician practices are engaging in new health care payment models intended to improve quality and reduce costs, but are finding that they need help with successfully managing increasing amounts of data and figuring out how to respond to the diversity of programs and quality metrics from different payers, according to a new joint study by the RAND Corporation and the American Medical Association.

23 Mar 2015

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec, Inc. today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology.

23 Mar 2015

Globavir, BioManguinhos partner to jointly evaluate PanGlob RT-PCR Dengue diagnostic assay

Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.

23 Mar 2015

Appriss partners with The MetroHealth System to fight drug abuse

Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced its partnership with The MetroHealth System in Ohio to fight drug abuse, diversion and addiction where it's needed most – at the prescribing level.

23 Mar 2015

Researchers explore impact of installing alcohol ignition interlock devices in vehicles

If every new car made in the United States had a built-in blood alcohol level tester that prevented impaired drivers from driving the vehicle, how many lives could be saved, injuries prevented, and injury-related dollars left unspent?

23 Mar 2015

Technology News and Research

Beaumont Health joins UHC and Novation to increase cost savings, improve supply chain performance

Confluence pharmaceuticals signs co-development and marketing agreement with AOP orphan for fragile X syndrome drug

GenVec reports record financial results for Q4 and fiscal year 2014

People who take many doses are more likely to crush tablets, reduce their effectiveness

Rigontec raises €4.8 million in second closing of Series A financing round

Newly identified proteins could shed light on the mechanisms of ALS

Harmful effects of smoking may be reflected in the facial movements of unborn babies

Snake-like robots follow the lead of real sidewinder rattlesnakes

Harris Health System uses sign language video technology to communicate with hearing-impaired patients

New targeted therapy promises to reduce frequency and intensity of breakouts

TGAC plans to use miniaturised sequencing device to conduct live environmental surveillance

Mast plans to develop vepoloxamer for chronic heart failure treatment

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

EHT expert paper raises important and unanswered questions about safety of wearable tech

OrthoSensor raises $19 million in Series C Preferred Stock financing

Study: Medical practices need support and guidance to adopt new payment models

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

Globavir, BioManguinhos partner to jointly evaluate PanGlob RT-PCR Dengue diagnostic assay

Appriss partners with The MetroHealth System to fight drug abuse

Researchers explore impact of installing alcohol ignition interlock devices in vehicles

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News